-
Patients with Friedreich’s Ataxia Show Improvements with Investigational EPI-743
Long-term use of EPI-743 (vatiquinone) can improve neurological function and prevent progression of Friedreich’s ataxia, Phase 2 trial results show. Read more about this trial and its findings here.
What are your thoughts about this news?
-
1 Reply
-
Good news! I commend all of the hard working doctors and everyone involved in curing FA
Log in to reply.